Know Cancer

or
forgot password

Assessment of Hematopoietic Recovery Following Chemotherapy for Non-Hodgknin's Lymphoma


N/A
18 Years
N/A
Not Enrolling
Both
Non-Hodgkin's Lymphoma

Thank you

Trial Information

Assessment of Hematopoietic Recovery Following Chemotherapy for Non-Hodgknin's Lymphoma


The first primary objective reflects a necessary and preliminary requirement: to reproduce
published results and validate the use of FLT-PET. In this study, 35 patients will be
selected to undergoing imaging with both FLT and FDG PET.


Inclusion Criteria:



- 18 years or older

- Women must not be pregnant or breast feeding

- Histologic diagnosis of non-Hodgkin's lymphoma (any stage)

- Must undergo treatment with chemotherapy and/or radiotherapy

Exclusion Criteria:

- May not have received previous therapy with radiopharmaceuticals

- May not have received prior therapy with cytotoxic chemotherapy and/or monoclonal
antibodies

Type of Study:

Observational

Study Design:

Observational Model: Case Control, Time Perspective: Prospective

Outcome Measure:

Staging and ReStaging scans

Outcome Time Frame:

after hematopoetic recovery

Safety Issue:

No

Authority:

United States: Food and Drug Administration

Study ID:

FLT-NHL

NCT ID:

NCT00775957

Start Date:

October 2008

Completion Date:

Related Keywords:

  • Non-Hodgkin's Lymphoma
  • Lymphoma
  • Lymphoma, Non-Hodgkin

Name

Location

University of Oklahoma Health Sciences CenterOklahoma City, Oklahoma  73104